Related references
Note: Only part of the references are listed.Mucosal vaccines - fortifying the frontiers
Ed C. Lavelle et al.
NATURE REVIEWS IMMUNOLOGY (2022)
A promising inactivated whole-virion SARS-CoV-2 vaccine
Irina Isakova-Sivak et al.
LANCET INFECTIOUS DISEASES (2021)
Spike mutation D614G alters SARS-CoV-2 fitness
Jessica A. Plante et al.
NATURE (2021)
Enhanced SARS-CoV-2 neutralization by dimeric IgA
Zijun Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Neutralizing antibody titres in SARS-CoV-2 infections
Eric H. Y. Lau et al.
NATURE COMMUNICATIONS (2021)
What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
Susanne H. Hodgson et al.
LANCET INFECTIOUS DISEASES (2021)
IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
Isabella Quinti et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
Vivek P. Chavda et al.
DRUG DISCOVERY TODAY (2021)
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
Matthias Becker et al.
NATURE COMMUNICATIONS (2021)
A guide to vaccinology: from basic principles to new developments
Andrew J. Pollard et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Using Protozoan Surface Proteins for Effective Oral Vaccination
Lucia Lara Rupil et al.
TRENDS IN PARASITOLOGY (2020)
The Status of Vaccine Development Against the Human Cytomegalovirus
Stanley A. Plotkin et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Ahmed O. Hassan et al.
CELL (2020)
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Julian Braun et al.
NATURE (2020)
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Masaki Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Ching-Lin Hsieh et al.
SCIENCE (2020)
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Jose Mateus et al.
SCIENCE (2020)
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations
Janet Sultana et al.
EXPERT REVIEW OF VACCINES (2020)
Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years
Chadi M. Saad-Roy et al.
SCIENCE (2020)
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Sandhya Bangaru et al.
SCIENCE (2020)
Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition
Oliver C. Grant et al.
SCIENTIFIC REPORTS (2020)
Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian Hamsters
Andrew Chak-Yiu Lee et al.
CELL REPORTS MEDICINE (2020)
A systematic review of SARS-CoV-2 vaccine candidates
Yetian Dong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins
Marianela C. Serradell et al.
NATURE COMMUNICATIONS (2019)
Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation
Fabien Pitoiset et al.
JOURNAL OF VIROLOGY (2017)
Vaccine Hesitancy Causes, Consequences, and a Call to Action
Daniel A. Salmon et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2015)
Enveloped virus-like particle platforms: vaccines of the future?
Fabien Pitoiset et al.
EXPERT REVIEW OF VACCINES (2015)
Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies
Shujing Wang et al.
PROTEIN & CELL (2015)
Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications
Eve Dube et al.
EXPERT REVIEW OF VACCINES (2015)
Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity
Marc Kirchmeier et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Virus-like particle-based vaccines against hepatitis C virus infection
Bertrand Bellier et al.
EXPERT REVIEW OF VACCINES (2013)
A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques
Pierre Garrone et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies
Bertrand Bellier et al.
VACCINE (2009)
Induction of secretory immunity and memory at mucosal surfaces
Per Brandtzaeg
VACCINE (2007)
Replication-competent vectors and empty virus-like particles: New retroviral vector designs for cancer gene therapy or vaccines
Charlotte Dalba et al.
MOLECULAR THERAPY (2007)
Mucosal immunity and vaccines
J Holmgren et al.
NATURE MEDICINE (2005)
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
F Chen et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
Share Paper
